Robert Di Scipio

Bob has over 30 years’ experience that spans corporate law and business development to general counsel and executive management in the life science and software industries. Prior to founding Skyland Analytics, Bob served as CEO of Aegis Analytical Corporation (acquired by Dassault Systèmes), VP of Business Development & Associate General Counsel at Martek Biosciences (NASDAQ:MATK), (acquired by DSM), and as General Counsel & VP Corporate Development of OmegaTech (acquired by Martek). Currently, Bob serves on the board of Sinopsys Surgical Inc. (medical device) and Skyland Analytics.

Dan Mitchell

Dan has been in the venture capital industry for 35 years. He began his venture career at the First National Bank of Chicago’s Institutional Venture Capital Fund, and then co-founded Capital Health Venture Partners, a healthcare-focused venture fund in 1985. In 1996 Dan co-founded Sequel Venture Partners. Sequel invested ~$400 million in seed and early stage opportunities primarily in the Front Range of Colorado. He is currently on the boards of ARCA Biopharma (Nasdaq: ABIO), Skyland Analytics, and Plato Biopharma.

Dave Withers

Dave has 25 years of experience as an entrepreneur, technology executive, angel investor and strategic advisor. Dave was the CEO and Co-Founder of Renasar Technologies that was acquired by EMC where he stayed on as VP of Technology for Global Platform Engineering through the acquisition by Dell. Prior to Renasar, Dave held operating and executive roles at Nebula, Ocarina (acquired by Dell), Isilon (acquired by EMC), PolyServe (acquired by HP), Access Graphics (acquired by GE), and APC (acquired by Schneider Electric). Dave holds an MBA in Finance from NYU and a BS in Decision and Information Sciences from Santa Clara University. He also serves on the Board of Directors of the Boys & Girls Clubs of Silicon Valley.